Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
Contribution of Intravenous Administration Components to Subvisible and Submicron Particles Present in Administered
Mark Pollo1, Anjali Mehta1, Kate Torres1
1Pfizer, Biotherapeutics/Pharmaceutical R&D - BioTherapeutics Pharmaceutical Sciences, Chesterfield, Missouri 63017.
Drug administration supplies, not just drug products, contribute significant particulate matter. Understanding these sources is crucial for predicting and controlling patient exposure to particulates.
Area of Science:
- Pharmaceutical Science
- Drug Delivery Systems
- Biomaterials
Background:
- Particulate matter in parenteral drugs poses risks to patients.
- Current controls focus on the finished drug product, not administration materials.
Purpose of the Study:
- To assess subvisible and submicron particulates from drug preparation and administration materials.
- To identify sources of extrinsic particulate matter in parenteral therapies.
Main Methods:
- Quantified particles from syringes, diluents, and IV supplies.
- Utilized light obscuration, flow imaging, and resistive pulse sensing.
Main Results:
- Disposable syringes, diluents, and IV supplies are significant sources of particulates.
- Each administration component contributes varying particulate loads.
- Particulate load delivered to patients is not solely from the drug product.
Conclusions:
- Administration method and supplies influence particulate levels in drug preparations.
- Controlling particulates requires considering both drug product and administration materials.
- Improved predictability of particulate levels is achievable with careful consideration of administration supplies.
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

